Please login to order a test.
- EBV in situ Hybridization
DNA probe hybridization for EBV in formalin-fixed, paraffin-embedded tissue
Detect EBV DNA sequences in tissue sections; adjunct to histopathology
Failure to detect target DNA may result from several factors, eg, improper sampling, handling, and/or fixative of the specimen, or target DNA below the sensitivity limits of the assay; therefore, lack of staining does not necessarily imply the absence of target DNA.
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.
In situ hybridization
Formalin-fixed, paraffin-embedded (FFPE) tissue biopsy. Tissue biopsies should be fixed in 10% neutral-buffered formalin and embedded in paraffin within 72 hours. Do not submit frozen tissue or substitute other fixatives. For tissues submitted in formalin, please provide the appropriate gross/microscopic description indicating the number, type, and sites of the tissue submitted.
Tissue biopsies should be fixed in 10% neutral buffered formalin and embedded in paraffin within 72 hours. Do not submit frozen tissue or substitute other fixatives. For tissues submitted in formalin, please provide appropriate gross/microscopic description indicating the number, type, and site of the tissue(s) submitted.
Maintain specimen at room temperature.
Causes for Rejection
Insufficient tissue; improper fixation; inappropriate fixative
Please direct any questions regarding this test to oncology customer service at 800-345-4363.